WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016102554) IMMUNOTHERAPEUTIC VACCINE COMPRISING E7 PROTEINS OF HPV16 AND HPV18 FUSED WITH CYAA, FOR USE IN SUBJECTS INFECTED WITH HPV
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/102554    International Application No.:    PCT/EP2015/080953
Publication Date: 30.06.2016 International Filing Date: 22.12.2015
IPC:
A61K 39/12 (2006.01), C07K 14/005 (2006.01), C07K 14/235 (2006.01), A61K 39/00 (2006.01), A61K 39/39 (2006.01)
Applicants: GENTICEL [FR/FR]; Rue Pierre et Marie Curie Prologue Biotech BP28262 31670 Labege (FR)
Inventors: MARUSSIG, Myriam; (FR).
TIMMERMAN, Benedikt; (FR)
Agent: GUTMANN, Ernest; 3, rue Auber 75009 Paris (FR)
Priority Data:
14307153.8 23.12.2014 EP
Title (EN) IMMUNOTHERAPEUTIC VACCINE COMPRISING E7 PROTEINS OF HPV16 AND HPV18 FUSED WITH CYAA, FOR USE IN SUBJECTS INFECTED WITH HPV
(FR) VACCIN IMMUNOTHÉRAPEUTIQUE COMPORTANT DES PROTÉINES H7 DE PVH16 ET PVH18 FUSIONNÉES AVEC CYAA, POUR UNE UTILISATION CHEZ DES SUJETS ATTEINTS DE PVH
Abstract: front page image
(EN)The invention relates to an immunotherapeutic vaccine for the treatment of infections by HPV16 or HPV18 or both HPV16 and HPV18 when the treated subject is selected from the group of human subjects infected with HPV16 or HPV18 or both (HPV16 and/or HPV18) and having no premalignant genital lesions related to said HPV(s), in particular no premalignant cervical lesions, and especially having no cancer related to said HPV infections, in particular no carcinomas related to said HPV infection.
(FR)L'invention concerne un vaccin immunothérapeutique pour le traitement d'infections par PVH16 ou PVH18 ou à la fois PVH16 et PVH18 lorsque le sujet traité est choisi parmi le groupe de sujets humains atteints de PVH16 ou PVH18 ou les deux (PVH16 et/ou PVH18) et n'ayant aucune lésion génitale pré-maligne, liée auxdits PVH, en particulier aucune lésion cervicale pré-maligne et, en particulier, n'ayant aucun cancer lié auxdites infections PVH, en particulier aucun carcinome lié à ladite infection PVH.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)